New data from an economic analysis presented today at this year’s European Society of Human Reproduction and Embryology (ESHRE) congress showed that…

Ferring is proud to announce the launch of its first Fertility Media Award (FIMA) today during the 25th Annual Society of Human Reproduction and Embryology (ESHRE) congress…

Ferring Pharmaceuticals announced today that Dr. John Patterson CBE FRCP has been appointed as a new Board Member with immediate effect…

The 2008 Frost & Sullivan European Human Growth Hormone Competitive Strategy Leadership Award is presented to Ferring Pharmaceuticals…

Today marks the European launch of FIRMAGON® (degarelix), a new treatment option in hormonal therapy for prostate cancer…

Today, Ferring Pharmaceuticals announced the creation of a new Executive Board…

Ferring Pharmaceuticals announced today that it has received marketing authorisation from the European Commission, for FIRMAGON® (degarelix)…

Ferring Pharmaceuticals, la société biopharmaceutique internationale, a annoncé aujourd’hui qu’elle a fait un don de 1 million à l’Université McGill de Montréal au Canada…

Today, Ferring Pharmaceuticals, the international bio-pharmaceutical company, announced a $1 million donation to McGill University of Montreal, Canada…

Ferring Pharmaceuticals, USA today received approval from the U.S. Food and Drug Administration (FDA) for degarelix…